BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20147586)

  • 1. Prospective randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.
    Mandell L
    Thorax; 2010 Feb; 65(2):93-4. PubMed ID: 20147586
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.
    Falguera M; Ruiz-González A; Schoenenberger JA; Touzón C; Gázquez I; Galindo C; Porcel JM
    Thorax; 2010 Feb; 65(2):101-6. PubMed ID: 19703825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of community-acquired pneumonia Down Under versus the United States: is it really that different?
    Mandell L
    Clin Infect Dis; 2008 May; 46(10):1522-4. PubMed ID: 18419485
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial empirical antibiotic treatment of community-acquired pneumonia].
    Frías J; Gomis M; Prieto J; Mensa J; Bouza E; García-Rodríguez JA; Torres A; Dorca J; Zalacaín R; García de Lomas J
    Rev Esp Quimioter; 1998 Sep; 11(3):255-61. PubMed ID: 9795313
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of community acquired pneumonia].
    Böszörményi Nagy G
    Orv Hetil; 2004 May; 145(22):1189-92. PubMed ID: 15279407
    [No Abstract]   [Full Text] [Related]  

  • 6. Performance measurement in community-acquired pneumonia: consequences intended and unintended.
    File TM; Gross PA
    Clin Infect Dis; 2007 Apr; 44(7):942-4. PubMed ID: 17342645
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.
    Schouten JA; Hulscher ME; Kullberg BJ; Cox A; Gyssens IC; van der Meer JW; Grol RP
    J Antimicrob Chemother; 2005 Sep; 56(3):575-82. PubMed ID: 16049096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited usefulness of initial blood cultures in community acquired pneumonia.
    Corbo J; Friedman B; Bijur P; Gallagher EJ
    Emerg Med J; 2004 Jul; 21(4):446-8. PubMed ID: 15208227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines for the management of community-acquired pneumonia in children.
    Lee PI; Chiu CH; Chen PY; Lee CY; Lin TY;
    Acta Paediatr Taiwan; 2007; 48(4):167-80. PubMed ID: 18265536
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.
    van der Eerden MM; Vlaspolder F; de Graaff CS; Groot T; Bronsveld W; Jansen HM; Boersma WG
    Thorax; 2005 Aug; 60(8):672-8. PubMed ID: 16061709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community acquired pneumonia.
    Loeb M
    Clin Evid; 2002 Jun; (7):1358-68. PubMed ID: 12230751
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumonia guidelines will affect 750,000 ED patients.
    Hosp Case Manag; 2004 Jun; 12(6):91-3. PubMed ID: 15195404
    [No Abstract]   [Full Text] [Related]  

  • 14. Community-acquired pneumonia in Malaysian patients: addition of macrolide and the use of BTS "curb" index to assess severity.
    Loh LC
    Med J Malaysia; 2006 Mar; 61(1):128-30. PubMed ID: 16708753
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization.
    Rosón B; Carratalà J; Verdaguer R; Dorca J; Manresa F; Gudiol F
    Clin Infect Dis; 2000 Oct; 31(4):869-74. PubMed ID: 11049763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it possible to blind a trial for community-acquired pneumonia?
    Boucher HW
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S210-5. PubMed ID: 18986292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 18. [Remarks on the comments regarding clinical recommendations for diagnosis and therapy of community-acquired pneumonia by Prof. Kolka].
    Skricková J
    Vnitr Lek; 2003 Jun; 49(6):452. PubMed ID: 14503472
    [No Abstract]   [Full Text] [Related]  

  • 19. In-hospital management of adults who have community-acquired pneumonia.
    Ortqvist A
    Semin Respir Infect; 1999 Jun; 14(2):135-50. PubMed ID: 10391408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of recent studies of community-acquired pneumonia.
    Higgins K; Singer M; Valappil T; Nambiar S; Lin D; Cox E
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S150-6. PubMed ID: 18986282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.